{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:24:11Z","timestamp":1793107451602,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1014896417653","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T21:20:03Z","timestamp":1041110403000},"page":"139-143","source":"Crossref","is-referenced-by-count":15,"title":["Urinary 2-Hydroxyestrone\/16\u03b1-Hydroxyestrone Ratio and Family History of Breast Cancer in Premenopausal Women"],"prefix":"10.1007","volume":"72","author":[{"given":"Giske","family":"Ursin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"London","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Chen","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C.","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Z.","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Gentzschein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"392593_CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1210\/endo-100-1-91","volume":"100","author":"JH Clark","year":"1977","unstructured":"Clark JH, Paszko Z, Peck Jr EJ: Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology 100: 91\u201396, 1977","journal-title":"Endocrinology"},{"key":"392593_CR2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jcem-51-3-611","volume":"51","author":"J Fishman","year":"1980","unstructured":"Fishman J, Martucci C: Biological properties of 16 alphahydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 51: 611\u2013615, 1980","journal-title":"J Clin Endocrinol Metab"},{"key":"392593_CR3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1210\/endo-101-6-1709","volume":"101","author":"C Martucci","year":"1977","unstructured":"Martucci C, Fishman J: Direction of estradiol metabolism as a control of its hormonal action \u2013 uterotrophic activity of estradiol metabolites. Endocrinology 101: 1709\u20131715, 1977","journal-title":"Endocrinology"},{"key":"392593_CR4","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1016\/S0021-9258(19)75968-7","volume":"261","author":"JG Liehr","year":"1986","unstructured":"Liehr JG, Ulubelen AA, Strobel HW: Cytochrome P-450-mediated redox cycling of estrogens. J Biol Chem 261: 16865\u201316870, 1986","journal-title":"J Biol Chem"},{"key":"392593_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.pa.36.040196.001223","volume":"36","author":"JD Yager","year":"1996","unstructured":"Yager JD, Liehr JG: Molecular mechanisms of estrogen carcinogenesis. Ann Rev Pharmacol Toxicol 36: 203\u2013232, 1996","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"392593_CR6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1749-6632.1986.tb16001.x","volume":"464","author":"HL Bradlow","year":"1986","unstructured":"Bradlow HL, Hershcopf R, Martucci C, Fishman J: 16 alphahydroxylation of estradiol: a possible risk marker for breast cancer. Ann N Y Acad Sci 464: 138\u2013151, 1986","journal-title":"Ann N Y Acad Sci"},{"key":"392593_CR7","first-page":"S259","volume":"150","author":"HL Bradlow","year":"1996","unstructured":"Bradlow HL, Telang NT, Sepkovic DW, Osborne MP: 2-hydroxyestrone: the 'good' estrogen. J Endocrinol 150: S259\u2013265, 1996","journal-title":"J Endocrinol"},{"key":"392593_CR8","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.79.9.3047","volume":"79","author":"J Schneider","year":"1982","unstructured":"Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J: Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci USA 79: 3047\u20133051, 1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"392593_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0022-4731(89)90138-6","volume":"34","author":"H Adlercreutz","year":"1989","unstructured":"Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S, Valtonen A, Ollus A: Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 34: 527\u2013530, 1989","journal-title":"J Steroid Biochem"},{"key":"392593_CR10","first-page":"505","volume":"6","author":"GC Kabat","year":"1997","unstructured":"Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL: Urinary estrogen metabolites and breast cancer: a case-control study (see comments). Cancer Epidemiol Biomark Prev 6: 505\u2013509, 1997","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"392593_CR11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/bjc.1998.663","volume":"78","author":"EN Meilahn","year":"1998","unstructured":"Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW, Kuller LH: Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 78: 1250\u20131255, 1998","journal-title":"Br J Cancer"},{"key":"392593_CR12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jnci\/91.12.1067","volume":"91","author":"G Ursin","year":"1999","unstructured":"Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC: Urinary 2-hydroxyestrone\/ 16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91: 1067\u20131072, 1999","journal-title":"J Natl Cancer Inst"},{"key":"392593_CR13","first-page":"294","volume":"27","author":"GH Ho","year":"1998","unstructured":"Ho GH, Luo XW, Ji CY, Foo SC, Ng EH: Urinary 2\/16 alpha-hydroxyestrone ratio: correlation with serum insulinlike growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann Acad Medic Singapore 27: 294\u2013 299, 1998","journal-title":"Ann Acad Medic Singapore"},{"key":"392593_CR14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00001648-200011000-00004","volume":"11","author":"P Muti","year":"2000","unstructured":"Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F: Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16 alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 11: 635\u2013640, 2000","journal-title":"Epidemiology"},{"key":"392593_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3109\/07357908809082132","volume":"8","author":"MP Osborne","year":"1988","unstructured":"Osborne MP, Karmali RA, Hershcopf RJ, Bradlow HL, Kourides IA, Williams WR, Rosen PP, Fishman J: Omega-3 fatty acids: modulation of estrogen metabolism and potential for breast cancer prevention. Cancer Invest 8: 629\u2013631, 1988","journal-title":"Cancer Invest"},{"key":"392593_CR16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jnci\/86.14.1076","volume":"86","author":"H Adlercreutz","year":"1994","unstructured":"Adlercreutz H, Gorbach SL, Goldin BR, Woods MN, Dwyer JT, Hamalainen E: Estrogen metabolism and excretion in Oriental and Caucasian women. J Natl Cancer Inst 86: 1076\u20131082, 1994","journal-title":"J Natl Cancer Inst"},{"key":"392593_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00001648-199209000-00006","volume":"3","author":"G Ursin","year":"1992","unstructured":"Ursin G, Aragaki CC, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW: Oral contraceptives and premenopausal bilateral breast cancer: a case-control study. Epidemiology 3: 414\u2013419, 1992","journal-title":"Epidemiology"},{"key":"392593_CR18","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/jnci\/86.18.1403","volume":"86","author":"L Bernstein","year":"1994","unstructured":"Bernstein L, Henderson BE, Hanisch R, Sullivan-Halley J, Ross RK: Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst 86: 1403\u20131408, 1994","journal-title":"J Natl Cancer Inst"},{"key":"392593_CR19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006037823178","volume":"50","author":"G Ursin","year":"1998","unstructured":"Ursin G, Ross RK, Sullivan-Halley J, Hanisch R, Henderson B, Bernstein L: Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat 50: 175\u2013184, 1998","journal-title":"Breast Cancer Res Treat"},{"key":"392593_CR20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0039-128X(94)90021-3","volume":"59","author":"TL Klug","year":"1994","unstructured":"Klug TL, Bradlow HL, Sepkovic DW: Monoclonal antibodybased enzyme immunoassay for simultaneous quantitation of 2-and 16 alpha-hydroxyestrone in urine. Steroids 59: 648\u2013655, 1994","journal-title":"Steroids"},{"key":"392593_CR21","first-page":"607","volume":"105","author":"RG Ziegler","year":"1997","unstructured":"Ziegler RG, Rossi SC, Fears TR, Bradlow HL, Adlercreutz H, Sepkovic D, Kiuru P, Wahala K, Vaught JB, Donaldson JL, Falk RT, Fillmore CM, Siiteri PK, Hoover RN, Gail MH: Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine. Environ Health Perspect 105: 607\u2013614, 1997","journal-title":"Environ Health Perspect"},{"key":"392593_CR22","first-page":"601","volume":"105","author":"G Ursin","year":"1997","unstructured":"Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC: A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer (see comments). Environ Health Perspect 105: 601\u2013605, 1997","journal-title":"Environ Health Perspect"},{"key":"392593_CR23","first-page":"3326","volume":"61","author":"G Ursin","year":"2001","unstructured":"Ursin G, Wilson M, Henderson BE, Kolonel LN, Monroe K, Lee HP, Seow A, Yu MC, Stanczyk FZ, Gentzschein E: Do urinary estrogen metabolites reflect the differences in breast cancer risk between Singapore Chinese and United States African\u2013American and white women? Cancer Res 61: 3326\u20133329, 2001","journal-title":"Cancer Res"},{"key":"392593_CR24","first-page":"627","volume":"10","author":"E Riza","year":"2001","unstructured":"Riza E, dos Santos Silva I, De Stavola B, Bradlow HL, Sepkovic DW, Linos D, Linos A: Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol Biomark Prev 10: 627\u2013634, 2001","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"392593_CR25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJM197510162931602","volume":"293","author":"BR Henderson","year":"1975","unstructured":"Henderson BR, Gerkins V, Rosario I, Casagrande J, Pike MC: Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 293: 790\u2013795, 1975","journal-title":"N Engl J Med"},{"key":"392593_CR26","first-page":"603","volume":"67","author":"D Trichopoulos","year":"1981","unstructured":"Trichopoulos D, Brown JB, Garas J, Papaioannou A, MacMahon B: Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients. J Natl Cancer Inst 67: 603\u2013606, 1981","journal-title":"J Natl Cancer Inst"},{"key":"392593_CR27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0014-2964(81)90290-5","volume":"17","author":"K Boffard","year":"1981","unstructured":"Boffard K, Clark GM, Irvine JB, Knyba RE, Bulbrook RD, Wang DY, Kwa HG: Serum prolactin, androgens, oestradiol and progesterone in adolescent girls with or without a family history of breast cancer. Eur J Cancer Clin Oncol 17: 1071\u2013 1077, 1981","journal-title":"Eur J Cancer Clin Oncol"},{"key":"392593_CR28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00008469-199708000-00004","volume":"6","author":"HC Jernstrom","year":"1997","unstructured":"Jernstrom HC, Olsson H, Borg A: Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19\u201325 years who were first and\/or second degree relatives to breast cancer patients. Eur J Cancer Prev 6: 330\u2013340, 1997","journal-title":"Eur J Cancer Prev"},{"key":"392593_CR29","first-page":"1884","volume":"43","author":"J Fishman","year":"1983","unstructured":"Fishman J, Bradlow HL, Fukushima DK, O'Connor J, Rosenfeld RS, Graepel GJ, Elston R, Lynch H: Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle. Cancer Res 43: 1884\u20131890, 1983","journal-title":"Cancer Res"},{"key":"392593_CR30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00051793","volume":"6","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Colditz GA, Hunter DJ, Manson JE, Willett WC, Stampfer MJ, Longcope C, Speizer FE: Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control 6: 217\u2013224, 1995","journal-title":"Cancer Causes Control"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014896417653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1014896417653\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1014896417653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1014896417653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:10:11Z","timestamp":1750479011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1014896417653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["392593"],"URL":"https:\/\/doi.org\/10.1023\/a:1014896417653","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}